Tactile Medical appoints Laura King to Board of Directors effective Jan 13, 2025

TACTILE SYSTEMS TECHNOLOGY INC

Laura King elected to Board; serves on Audit and Compliance & Reimbursement Committees.
King brings 22-year GE Healthcare tenure as President & CEO of Global Interventional Business.
Initial RSU grant valued at pro rata portion of $145,000, vesting earlier of one year or 2025 annual meeting.
Annual cash retainers: $50,000 board, $10,000 audit committee, $5,000 compliance committee.
King also co-founder & CEO of BiaCure; formerly led NeuWave Medical (acquired by J&J).

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Laura G. King

Director

TCMD · TACTILE SYSTEMS TECHNOLOGY INC

Effective: 2025-01-13
Filed: January 13, 2025, 6:59 PM ET

the board of directors of Tactile Systems Technology, Inc. (the “Company”) elected Laura G. King to serve as a member of the board and fixed the size of the board at nine directors, all effective as of January 13, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Laura G. King was elected as Director at TACTILE SYSTEMS TECHNOLOGY INC.

Action: elected
Role: Director

Exact text from the filing

the board of directors of Tactile Systems Technology, Inc. (the “Company”) elected Laura G. King to serve as a member of the board and fixed the size of the board at nine directors, all effective as of January 13, 2025.

View on SEC.gov

TACTILE SYSTEMS TECHNOLOGY INC filing history →

Source: SEC EDGAR

accession 0001104659-25-002876

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.